Quarterly report · Q2
4202.TEDINET S100PIOQ
Period2022-04-01 → 2022-09-30
Filed2022-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥266.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥467.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥224.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥26.0bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥27.3bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥30.2bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥57.3bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥29.8bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥32.5bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥29.6bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥22.2bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥31.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥22.0bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥22.8bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥22.3bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥746.2bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥698.8bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥674.0bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥434.9bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥419.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥311.4bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥279.5bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥274.3bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥85.8bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥88.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥85.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥88.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥90.9bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥90.7bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥7.8bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥43.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥28.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥17.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥46.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥21.3bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥7.5bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥75.08 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.97 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥104.14 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥73.15 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.39 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 40.7% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.8% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 59
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥9.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥3.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥6.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥118m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥13.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥13.9bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥123.7bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥123.6bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥157m |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥14.5bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥11.0bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥10.9bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥103m |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥39.7bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥39.7bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥364m |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥16.2bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥16.2bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥74m |
| jpcrp040300-q2r_E00818-000Smartreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥373m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥270.4bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥262.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥7.7bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥25.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥280.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥266.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥13.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥26.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥11.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥5.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥6.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥461m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥16.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥16.6bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥104.5bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥104.4bn |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥155m |
| jpcrp040300-q2r_E00818-000Engineering Plasticsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥13.2bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥9.9bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥9.6bn |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥282m |
| jpcrp040300-q2r_E00818-000Medical Healthcarereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥32.4bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥31.9bn |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥527m |
| jpcrp040300-q2r_E00818-000Safetyreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥15.7bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥15.4bn |
| jpcrp040300-q2r_E00818-000Smartreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥230m |
| jpcrp040300-q2r_E00818-000Smartreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥2.6bn |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥230.0bn |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥219.4bn |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥10.6bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥26.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥241.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥224.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥16.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥27.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 577
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 10569000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 6038000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 16607000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -16607000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00818-000MedicalHealthcareReportableSegmentsMember | 9916000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00818-000SmartReportableSegmentsMember | 15675000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00818-000SafetyReportableSegmentsMember | 32424000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00818-000MaterialsReporatbleSegmentsMember | 67424000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00818-000EngineeringPlasticsReportableSegmentsMember | 104547000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 229988000000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 11437000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 241425000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -16607000000 | JPY |
| Net sales | Prior1YTDDuration | 224817000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00818-000MedicalHealthcareReportableSegmentsMember | 1395000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00818-000SmartReportableSegmentsMember | 2576000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00818-000SafetyReportableSegmentsMember | 1072000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00818-000MaterialsReporatbleSegmentsMember | 8599000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E00818-000EngineeringPlasticsReportableSegmentsMember | 13152000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 26797000000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 461000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 27259000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1YTDDuration | 27259000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00818-000MedicalHealthcareReportableSegmentsMember | 10886000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00818-000SmartReportableSegmentsMember | 16164000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00818-000SafetyReportableSegmentsMember | 39745000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00818-000MaterialsReporatbleSegmentsMember | 72359000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E00818-000EngineeringPlasticsReportableSegmentsMember | 123559000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 262715000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 3517000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 266232000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 266232000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00818-000MedicalHealthcareReportableSegmentsMember | 103000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00818-000SmartReportableSegmentsMember | 74000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00818-000SafetyReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00818-000MaterialsReporatbleSegmentsMember | 7397000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E00818-000EngineeringPlasticsReportableSegmentsMember | 157000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | 7732000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 6200000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 13933000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | -13933000000 | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00818-000MedicalHealthcareReportableSegmentsMember | 10989000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00818-000SmartReportableSegmentsMember | 16238000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00818-000SafetyReportableSegmentsMember | 39745000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00818-000MaterialsReporatbleSegmentsMember | 79756000000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E00818-000EngineeringPlasticsReportableSegmentsMember | 123717000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |